Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.

Jenei K, Raymakers AJN, Bayle A, Berger-Thürmel K, Cherla A, Honda K, Jackson CCGA, Karikios D, Trapani D, Berry S, Gyawali B.

Open source

DOI
10.1016/s1470-2045(23)00175-4
Published
2023-06-01
Container
Lancet Oncol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-23-00175-4,
  title = {Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.},
  author = {Jenei K and  Raymakers AJN and  Bayle A and  Berger-Thürmel K and  Cherla A and  Honda K and  Jackson CCGA and  Karikios D and  Trapani D and  Berry S and  Gyawali B.},
  year = {2023},
  journal = {Lancet Oncol},
  doi = {10.1016/s1470-2045(23)00175-4},
  url = {https://doi.org/10.1016/s1470-2045(23)00175-4}
}

RIS

TY  - JOUR
TI  - Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.
AU  - Jenei K
AU  -  Raymakers AJN
AU  -  Bayle A
AU  -  Berger-Thürmel K
AU  -  Cherla A
AU  -  Honda K
AU  -  Jackson CCGA
AU  -  Karikios D
AU  -  Trapani D
AU  -  Berry S
AU  -  Gyawali B.
PY  - 2023
JO  - Lancet Oncol
DO  - 10.1016/s1470-2045(23)00175-4
UR  - https://doi.org/10.1016/s1470-2045(23)00175-4
ER  - 

APA

K, J., AJN, R., A, B., K, B., A, C., K, H., CCGA, J., D, K., D, T., S, B., & B., G. (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.. Lancet Oncol. https://doi.org/10.1016/s1470-2045(23)00175-4

Source records